Rhythm

Data Reinforce Reduced Complications with Medtronic Micra Transcatheter Pacing System Over Traditional Pacemakers in Real-World Use

DUBLIN and BOSTON – May 9, 2018 – Medtronic plc (NYSE: MDT) today announced that results through 12-months from the Post-Approval Registry (PAR) for the Medtronic Micra(TM) Transcatheter Pacing System (TPS), reinforcing the high implant success rate and low complication rate seen since its U.S. approval two years ago, will be […]

Results from Imricor MRI-Guided Cardiac Ablation Study to Be Presented at Heart Rhythm Society Conference in Boston

MINNEAPOLIS–(BUSINESS WIRE)– Imricor Medical Systems announced today that the results from the clinical study to evaluate Imricor’s Vision-MRTM Ablation Catheter for the treatment of atrial flutter under real-time MRI guidance will be presented this week at the Heart Rhythm Society (HRS) conference in Boston. Philipp Sommer MD will present the study results on […]

NRG® Transseptal Needle Associated with a 40% Lower Risk of Silent Cerebral Embolism

TORONTO, May 8, 2018 /PRNewswire/ – A recent study published in Heart and Vessels has found that the use of the Baylis Medical NRG® radiofrequency (RF) Transseptal Needle for transseptal punctures was linked to a 40% lower incidence of silent acute cerebral embolism in atrial fibrillation (AF) ablation procedure patients.1 The study publication follows a […]

Heart Rhythm Society Kicks Off Annual Scientific Sessions In Boston To Unveil Scientific Advances And Innovations In Cardiac Arrhythmia Care

BOSTON, May 8, 2018 /PRNewswire/ — Thousands of clinicians, scientists, researchers and innovators from around the world will gather together Wednesday, May 9 through Saturday, May 12 at the Boston Convention and Exhibition Center for Heart Rhythm 2018, the Heart Rhythm Society’s (HRS) 39th Annual Scientific Sessions, to explore recent developments in the field of cardiac pacing […]

First Cardiac Procedure Using the AcQMap® System by Acutus Medical® Successfully Performed in the United States

CARLSBAD, Calif., May 8, 2018 /PRNewswire/ — Acutus Medical®, a global heart rhythm technology company, today announced that the AcQMap® High Resolution Imaging and Mapping System has been utilized for the first time in U.S. patients. The company also revealed initiation of a new clinical study to evaluate the technology during atrial fibrillation retreatment […]

Cardiva Medical Announces Completion of the AMBULATE Pivotal Trial Evaluating the VASCADE MVP System for Multi-Vessel Closure Following Electrophysiology Procedures

SANTA CLARA, Calif.–(BUSINESS WIRE)–Cardiva Medical, Inc., an innovator in the field of vascular closure, today announced the completion of the AMBULATE pivotal trial, one of several clinical trials in the company’s AMBULATE series that are studying the VASCADE MVP Venous Vascular Closure System for use in the closure of mid-bore […]

Affera’s Novel Technology For Cardiac Arrhythmia Treatment To Be Featured In 8 Scientific Sessions At The 2018 Heart Rhythm Society Meeting

WATERTOWN, Mass., May 7, 2018 /PRNewswire/ — Affera, Inc, a private medical device company focused on innovative cardiac arrhythmia treatment solutions, announced today its integrated platform will be highlighted in eight scientific sessions at the Heart Rhythm Society 2018 (HRS) meeting in Boston, Massachusetts. Affera’s revolutionary lesion formation technology offers a solution designed to optimize procedural efficiency […]

Bardy Diagnostics™ Announces Results of Head-to-Head Comparison of Patch-Based Arrhythmia Monitors

SEATTLE, May 7, 2018 /PRNewswire/ — Bardy Diagnostics, Inc., (“BardyDx”), a leading provider of ambulatory cardiac monitoring technologies and custom data solutions, including the Carnation Ambulatory Monitor (“CAM™”), the world’s only P-wave centric™ ambulatory cardiac monitor and arrhythmia detection device, announced today that the American Heart Journal has published the results of a head-to-head […]

Biosense Webster, Inc. Launches Study To Evaluate Novel High Power, Short Duration Modality For Treatment Of Atrial Fibrillation

IRVINE, Calif., May 2, 2018 /PRNewswire/ — Johnson & Johnson Medical Devices Companies* announced today that Biosense Webster, Inc., a worldwide leader in the diagnosis and treatment of heart arrhythmias, has enrolled and treated the first patient in its QDOT AF Study.** The study will evaluate the delivery of high power, short duration ablation […]

CardioFocus® Announces FDA Approval Of The Next-Generation HeartLight® Excalibur Balloon™ Designed For The Treatment Of Paroxysmal Atrial Fibrillation*

MARLBOROUGH, Mass., May 7, 2018 /PRNewswire/ — CardioFocus, Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted approval for the HeartLight Excalibur Balloon, a next-generation technology designed for the treatment of paroxysmal atrial fibrillation (PAF)*. The Excalibur Balloon leverages the proven universal balloon design of the company’s FDA-approved HeartLight® Endoscopic Ablation System and introduces an […]